| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1219612B1 2-imino-1,3-thiazine derivatives |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166742A Novel lactam compound |
| 04/23/2008 | CN101166706A Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN101164598A Traditional Chinese medicine for treating infantile acute nephritis |
| 04/23/2008 | CN101164593A Oral liquid for treating kidney disease |
| 04/23/2008 | CN101164592A Traditional Chinese medicine extract for treating chronic nephritis, capsule and preparation method |
| 04/23/2008 | CN101164581A Traditional Chinese medicine for treating acute and chronic prostate disease and preparation technology thereof |
| 04/23/2008 | CN101164569A Heat clearing stone eliminating and stone dissolving decoction |
| 04/23/2008 | CN101164541A Treatment of urinary dysfunction |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383126C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/23/2008 | CN100382825C Chinese patent medicine for treating astenia wind-heat syndrome and preparing method |
| 04/23/2008 | CN100382814C Chinese medicine preparation for invigorating liver and kidney and its preparing method |
| 04/23/2008 | CN100382805C Azithromycin enteric casing microsphere and its preparing process |
| 04/23/2008 | CN100382797C Confected product containing lutein and/or carotene linolenic acid, and its preparation method |
| 04/23/2008 | CN100382794C Dispersed tablet of tartaric acid tolterodine tartrate |
| 04/23/2008 | CN100382789C Orally administered dripping pills with diuresis inducing function and preparation process thereof |
| 04/23/2008 | CN100382788C Drop pill for treating hematuresis and process for preparing the same |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361690 Compositions and methods for the treatment of urinary incontinence |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361668 Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | US7361633 Treating sex-hormone dependent tumors and cancer such as benign prostate hyperplasia and uterine fibroids with the decapeptide: Ac-D-Nal(2)-D-4-ClPhe-D-Pal-Ser-1 MePal-D-IsopropylLys-Leu-lsopropylLys-Pro-D-AlaNH2 |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2356109C Insulin-like growth factor (igf) i mutant variants |
| 04/22/2008 | CA2297082C Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 04/17/2008 | WO2008046084A2 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008046065A1 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008043243A1 Use of hydrochloric acid in manufacture of medicament for treating disease caused by fouling of transport tract |
| 04/17/2008 | US20080091034 Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds |
| 04/17/2008 | US20080090916 2-Amino-4-[(1S,2R)-2-(2,5-dimethoxyphenyl)-2-hydroxy-1-methyl-ethylcarbamoyl]butyric acid, aka gamma-L-glutamyl-1R,2S-methoxamine; prodrug of 1R,2S-methoxamine that is converted within the kidney tubules into its active form; transdermal administration; coupling methoxamine with glutamic acid alcohol |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090845 Haloalkyl-substituted pyrimidinone derivatives |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080089884 For treating and/or preventing bladder disorders; for decreasing the expression, release or biological activity of macrophage migration inhibition factor |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089869 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 04/17/2008 | CA2664920A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1909812A2 Small compounds that correct protein misfolding and uses thereof |
| 04/16/2008 | EP1909802A2 Steroidal glycoside compounds as core 2 glcnac-t inhibitors |
| 04/16/2008 | EP1909785A2 Use of progesterone receptor modulators |
| 04/16/2008 | EP1909757A2 Oral liquid losartan compositions |
| 04/16/2008 | EP1567526B1 Carbamic acid esters with anticholinergic action |
| 04/16/2008 | EP1361885B1 Use of gamma-gt inhibitors for the treatment of chronic degenerative diseases |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | CN101161646A Ketones compound preventing cells from oxidation damage, preparation method and uses thereof |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161262A A medicine for treating chronic renal failure and its preparing method |
| 04/16/2008 | CN100381462C Peptides and medicinal compositions containing the same |
| 04/16/2008 | CN100381461C Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 04/16/2008 | CN100381120C Fibrauretine powder for injection and its production process |
| 04/16/2008 | CN100381066C Method for preparing bone-strengthening kidney-benefiting fatigue-alleviating milk powder with micron deer bone powder, dragon's bone powder, pine pollen and king solomonseal rhizome powder |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358260 Quinuclidine derivatives and medicinal compositions containing the same |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/15/2008 | CA2328920C Novel derivatives of 3,3-diphenylpropylamines |
| 04/10/2008 | WO2008042688A2 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 04/10/2008 | WO2008040774A2 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 04/10/2008 | WO2008040236A1 Flavones derivatives, preparation methods and uses thereof |
| 04/10/2008 | WO2008040187A1 Application of astilbin in preparation of medicament for treating or preventing acute or chronic renal failure, kidney fibrosis and diabetic renopathy |
| 04/10/2008 | WO2008012546A3 Azapeptides for use in therapy against interstitial cystitis |
| 04/10/2008 | WO2007047430A8 Method of treating acute failure with thrombomodulin variant |
| 04/10/2008 | US20080085938 Arylamino-Arylpropanolamine Derivatives and Methods of Their Use |
| 04/10/2008 | US20080085916 Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators |
| 04/10/2008 | US20080085897 Inhibitors of cyclic guanosine monophosphate-metabolizing phosphodiesterases (cGMP PDE); cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia; 2-[2-ethoxy-5-(4-methyl-piperazine-1-sulphonyl)-phenyl]-5,7-dimethyl-3H-imidazo-[5,1-f]-[1,2,4]triazin-4-one for example |
| 04/10/2008 | US20080085324 Compositions and methods for detecting and treating renal injury and inflammation |
| 04/10/2008 | US20080085280 Using monoclonal antibody specific to bacterial ectodomain as tool in prevention and treatment of pancreatic, kidney and inflammatory disorders |
| 04/10/2008 | CA2665435A1 Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 04/10/2008 | CA2664688A1 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
| 04/09/2008 | EP1908765A1 Thienopyrimidine derivative |
| 04/09/2008 | EP1908753A1 Novel heterocyclidene acetamide derivative |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |
| 04/09/2008 | EP1908469A1 Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| 04/09/2008 | EP1906957A1 Novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders |
| 04/09/2008 | EP1906944A1 Schisandrin b preparation |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1123368B1 Method of extracting lipids from marine and aquatic animal tissues |